Skip to main content
. 2021 Jul 15;16:100299. doi: 10.1016/j.bbih.2021.100299

Table 1.

Subject characteristics Data is presented as mean with standard deviations (SD) for parametric data and as median (25th-75th interquartile range) for non-parametric data. Frequencies are presented with percentages (%). Age is rounded to the nearest year. ACE-I: Angiotensin converting enzyme inhibitor. ARB: angiotensin receptor blocker.

Age (y) 56 (36–61)
Female sex (n; %) 9 (52.9%)
Co-morbidities (n; %)
Asthma 5 (29.4%)
Atherosclerotic cardiovascular disease 0
Diabetes mellitus 1 (5.9%)
Current smoker 4 (23.5%)
Hypertension 2 (11.8%)
Active cancer 0 (0%)
Inflammatory arthritis 4 (23.5%)
At least one cardiovascular medication (n; %) 4 (23.5%)
Beta blocker 1 (5.9%)
Calcium channel blocker 1 (5.9%)
Diuretic 1 (5.9%)
Statin 1 (5.9%)
ARB/ACE-I 0
Nitrate 1 (5.9%)
NSAIDs 2 (11.8%)
Opioids 1 (5.9%)
Antidepressant 2 (11.8%)
Steroid/immunosuppresant 0